Neoplasms, Connective and Soft Tissue  >>  dacarbazine  >>  Phase 3
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
dacarbazine / Generic mfg.
NCT01343277 / 2016-000929-40: A Study of Trabectedin or Dacarbazine for the Treatment of Patients With Advanced Liposarcoma or Leiomyosarcoma

Completed
3
579
US, RoW
Trabectedin, Dacarbazine
Janssen Research & Development, LLC, PharmaMar
Advanced Liposarcoma or Leiomyosarcoma
01/15
04/16
NCT01692678: A Study of Trabectedin (YONDELIS) in Patients With Locally Advanced or Metastatic Liposarcoma or Leiomyosarcoma

Completed
3
16
RoW
Trabectedin, YONDELIS, Dacarbazine
Xian-Janssen Pharmaceutical Ltd.
Advanced or Metastatic Liposarcoma or Leiomyosarcoma
10/16
10/16

Download Options